Company Intelligence

Biolinco

Biolinco develops an AI-enabled, high-throughput cell line screening platform for biopharmaceutical manufacturers to efficiently identify optimal cell lines using DNA barcoding technology, addressing the issue of low-yielding cell lines

In this profile

Quick Facts

  • Founded 2026
  • Headquarters Baltimore, Americas
  • Country Americas
  • Industry AI in Enterprise Software
  • Company Type Techstars AI Health Baltimore
  • Status Active
  • Website Official site
  • Last Reviewed Aug 2026

Executive Summary

Biolinco develops an AI-enabled, high-throughput cell line screening platform for biopharmaceutical manufacturers to efficiently identify optimal cell lines using DNA barcoding technology, addressing the issue of low-yielding cell lines

Why It Matters

Biolinco appears in the public Techstars AI Health Baltimore portfolio (open accelerator dataset).

Products

Recent Developments

  1. 2026 Company founded

    Biolinco was founded in 2026 per the company profile source on file.

    Source

Connected Reports

Connected Insights

Industries

Biolinco develops an AI-enabled, high-throughput cell line screening platform for biopharmaceutical manufacturers to efficiently identify optimal cell lines using DNA barcoding technology, addressing the issue of low-yielding cell lines

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe